Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Acute Anterior Wall Myocardial Infarction

fluorodeoxyglucose f18 has been researched along with Acute Anterior Wall Myocardial Infarction in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, Y; Bom, HS; Cho, JG; Cho, JY; Chong, A; Hong, YJ; Jang, SY; Jeong, HC; Jeong, IS; Jeong, MH; Kang, JC; Kim, HK; Kim, J; Kim, JH; Kim, JM; Kim, KH; Kim, MS; Kim, SS; Lee, KH; Lim, KS; Oh, SG; Park, DS; Park, HW; Park, JC; Park, KH; Ryu, SH; Sim, DS; Song, HC; Yoon, HJ; Yoon, NS1
Choi, BJ; Choi, SY; Hwang, GS; Kang, SJ; Lim, HS; Sheen, SS; Shin, JH; Tahk, SJ; Yang, HM; Yoon, MH1

Other Studies

2 other study(ies) available for fluorodeoxyglucose f18 and Acute Anterior Wall Myocardial Infarction

ArticleYear
Cardioprotective effect of fimasartan, a new angiotensin receptor blocker, in a porcine model of acute myocardial infarction.
    Journal of Korean medical science, 2015, Volume: 30, Issue:1

    Topics: 3-Iodobenzylguanidine; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anterior Wall Myocardial Infarction; Biphenyl Compounds; Cardiotonic Agents; Disease Models, Animal; Echocardiography; Fluorodeoxyglucose F18; Perindopril; Positron-Emission Tomography; Pyrimidines; Random Allocation; Swine; Tetrazoles; Tomography, Emission-Computed, Single-Photon; Valsartan; Ventricular Function, Left

2015
Usefulness of the index of microcirculatory resistance for invasively assessing myocardial viability immediately after primary angioplasty for anterior myocardial infarction.
    European heart journal, 2009, Volume: 30, Issue:23

    Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Anterior Wall Myocardial Infarction; Coronary Circulation; Coronary Vessels; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Microcirculation; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Survival; Vascular Resistance; Ventricular Function, Left

2009